Cannabinoid WIN55,212-2 restores bronchial epithelium by regulating oxidative stress and STAT6 phosphorylation
Journal of Allergy and Clinical Immunology · 2025
DOI: 10.1016/j.jaci.2025.05.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2025. Verfasst von Mario Pérez-Diego und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, School of Chemistry, Complutense University of Madrid, Madrid, Spain. Hauptthemen laut MEDLINE: Benzoxazines, Morpholines, Naphthalenes, Oxidative Stress. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, European Academy of Allergy and Clinical Immunology, Universidad Complutense de Madrid.
Abstract (Originalsprache)
BACKGROUND: Viral infections and type 2 immune responses perpetuate airway epithelial barrier dysfunction and inflammation, leading to the development and progression of asthma. The synthetic cannabinoid WIN55,212-2 displays anti-inflammatory properties by acting on different immune system cells. OBJECTIVE: We sought to investigate the capacity of WIN55,212-2 to restore bronchial epithelial barrier function in asthma in the context of viral infections or type 2-driven inflammation. METHODS: Air-liquid interface cultures of human bronchial epithelial cells and human bronchial epithelial spheroids were generated to assess the capacity of WIN55,212-2 to restore airway epithelial barrier damage induced by human rhinovirus A16 (RV-A16) infection or type 2 inflammation. RT-PCR, cytokine quantification, permeability assays, metabolic studies, flow cytometry, and Western blot techniques were employed to assess the effects of WIN55,212-2 on the airway epithelium. The in vivo relevance of our findings was evaluated in a murine model of IL-13-induced airway inflammation. RESULTS: Prophylactic and therapeutic administration of WIN55,212-2 accelerated the recovery from RV-A16-induced bronchial epithelial barrier damage. WIN55,212-2 inhibited the acquisition of IL-13-induced type 2 asthma features in air-liquid interface cultures, self-assembled bronchial epithelial spheroids, and in vivo asthma model of airway inflammation and epithelial dysfunction. Mechanistically, WIN55,212-2 impaired IL-13-induced oxidative stress in epithelial cells, restoring the activity of protein tyrosine phosphatases, which in turn inhibited pSTAT6-mediated signaling pathways and asthma features. CONCLUSIONS: The cannabinoid WIN55,212-2 displays airway epithelial barrier protective effects during RV-A16 infection or type 2 inflammation by mechanisms associated with the modulation of oxidative metabolism and pSTAT6-mediated signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, School of Chemistry, Complutense University of Madrid, Madrid, Spain.
- Swiss Institute of Allergy and Asthma Research, University of Zurich, Davos, Switzerland.
- Department of Biochemistry and Molecular Biology, School of Chemistry, Complutense University of Madrid, Madrid, Spain; Department of Biochemistry and Molecular Biology, School of Pharmacy, Complutense University of Mad…
- Department of Organic Chemistry, School of Optics and Optometry, Complutense University of Madrid, Madrid, Spain.
- Department of Biochemistry and Molecular Biology, School of Chemistry, Complutense University of Madrid, Madrid, Spain. Electronic address: oscar.palomares@quim.ucm.es.
Förderung
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- European Academy of Allergy and Clinical Immunology
- Universidad Complutense de Madrid
- Ministerio de Economía y Competitividad
- Ministerio de Universidades
- Gobierno de España Ministerio de Ciencia e Innovación
Zitieren
APA
Pérez-Diego, M., Angelina, A., Pat, Y., Maldonado, A., Sevilla-Ortega, C., Martín-Cruz, L., Yazici, D., Rückert, B., Sokolowska, M., Martín-Fontecha, M., Akdis, M., Akdis, C. A., & Palomares, O. (2025). Cannabinoid WIN55,212-2 restores bronchial epithelium by regulating oxidative stress and STAT6 phosphorylation. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2025.05.002
Vancouver
Pérez-Diego M, Angelina A, Pat Y, Maldonado A, Sevilla-Ortega C, Martín-Cruz L, et al. Cannabinoid WIN55,212-2 restores bronchial epithelium by regulating oxidative stress and STAT6 phosphorylation. Journal of Allergy and Clinical Immunology. 2025. doi:10.1016/j.jaci.2025.05.002
BibTeX
@article{PrezDiego2025,
author = {Pérez-Diego, Mario and Angelina, Alba and Pat, Yağız and Maldonado, Angel and Sevilla-Ortega, Carmen and Martín-Cruz, Leticia and Yazici, Duygu and Rückert, Beate and Sokolowska, Milena and Martín-Fontecha, Mar and Akdis, Mübeccel and Akdis, Cezmi A and Palomares, Oscar},
title = {Cannabinoid WIN55,212-2 restores bronchial epithelium by regulating oxidative stress and STAT6 phosphorylation},
journal = {Journal of Allergy and Clinical Immunology},
year = {2025},
doi = {10.1016/j.jaci.2025.05.002}
}
EUVIMED